Gregory Gene Freitag - Jul 14, 2023 Form 4 Insider Report for PDS Biotechnology Corp (PDSB)

Role
Director
Signature
/s/ Spencer Brown, as Attorney-in-Fact
Stock symbol
PDSB
Transactions as of
Jul 14, 2023
Transactions value $
$0
Form type
4
Date filed
7/17/2023, 05:30 PM
Previous filing
Jun 5, 2023
Next filing
Sep 7, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PDSB Employee Stock Option (Right to Buy) Award $0 +9K $0.00 9K Jul 14, 2023 Common Stock 9K $5.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.